Table 1 Summary of the healthy controls and patients used in this study
Cell line code | Status | Code used in this study | Sex | Age at donation | Age at onset | LRRK2 mutation | Isogenic control |
|---|---|---|---|---|---|---|---|
SP-11 | Control | CTL | F | 48 | – | No | – |
SP-09 | Control | CTL | M | 66 | – | No | – |
SP-12 | L2-PD | L2-PD1 | F | 63 | 49 | G2019S | – |
SP-13 | L2-PD | L2-PD2 | F | 68 | 57 | G2019S | – |
SP-12 wt/wt | Isogenic Control | L2-PD1corr | F | 63 | – | G2019S | LRRK2G2019S corrected |
SP-13 wt/wt | Isogenic Control | L2-PD2corr | F | 68 | – | G2019S | LRRK2G2019S corrected |
